Brochure: EPI2ME — data analysis for all levels of expertise
- Oncology
- 16S
- AAV
- AMR
- Assembly
- Bacteria
May 1 2025
White paper: accelerating cancer research through comprehensive genomic analysis
- Oncology
- Cancer research
- Human genomics
- Assembly
- Long-read
- Bioinformatics
April 9 2025
Case study: accurate identification of cancer-predisposing deep intronic variants in tumour-suppressor genes with Oxford Nanopore sequencing
- Oncology
- Cancer research
- Adaptive sampling
- DNA
- cDNA
April 7 2025
Case study: solving the parent-of-origin effect in retinoblastoma to determine disease severity
- Oncology
- Adaptive sampling
- Assembly
- Gene expression
- Human genomics
- Long-read
April 4 2025
Case study: improving the characterisation of acute paediatric leukaemia worldwide
- Oncology
- Adaptive sampling
- Cancer research
- Gene fusions
April 4 2025
London Calling 2024 technology update
- Oncology
- Adaptive sampling
- Assembly
- Automation
- Basecalling
- Bioinformatics
May 24 2024
TEQUILA-seq: a versatile and low-cost method for targeted long-read RNA sequencing
- Oncology
- Splice variation
- MinION
- GridION
- Transcriptome
- Sequence capture
August 8 2023
Long-read sequencing of diagnosis and post-therapy medulloblastoma reveals complex rearrangement patterns and epigenetic signatures
- Oncology
- PromethION
- Cancer research
- Long-read
- Structural variation
- Epigenetics
March 22 2023
Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing
- Oncology
- RNA
- Transcriptome
- Gene expression
- Cancer research
- Long-read
February 9 2023
NCM 2022: Finding the needle — haplotype-resolved discovery and annotation of clinically relevant genetic and epigenetic variants using whole-genome nanopore sequencing
- Oncology
- Microbiology
- Epigenetics
- Clinical research
- Nanopore Community Meeting
December 7 2022
NCM 2022: Clinical and functional significance of germline variation in cancer susceptibility and disease
- Oncology
- Cancer research
- Structural variation
- Nanopore Community Meeting
December 7 2022
Rapid-CNS2: Rapid comprehensive adaptive nanopore-sequencing of CNS tumors, a proof of concept study
- Oncology
- Cancer research
- Real-time
- MinION
- Variant calling
- Clinical research
March 22 2022
ACME: an Affinity-based Cas9 Mediated Enrichment method for targeted nanopore sequencing
- Oncology
- Long-read
- Targeted
- DNA
- Structural variation
- Human genomics
February 5 2022
Whole genome assembly of human papillomavirus by nanopore long-read sequencing
- Oncology
- Cancer research
- Clinical research
- Microbiology
- Infectious disease
- MinION
January 4 2022
Accurate detection of circulating tumor DNA using nanopore consensus sequencing
- Oncology
- Clinical research
- Cancer research
- Human genomics
- cfDNA
- DNA
December 9 2021
Single-molecule RNA sequencing reveals IFNγ-induced differential expression of immune escape genes in merkel cell polyomavirus–positive MCC cell lines
- Oncology
- MinION
- RNA
- cDNA
- Gene expression
- Cancer research
November 22 2021
Extrachromosomal amplification of human papillomavirus episomes as a mechanism of cervical carcinogenesis
- Oncology
- Long-read
- Targeted
- gDNA
- DNA
- Cancer research
October 24 2021
Intraoperative DNA methylation classification of brain tumors impacts neurosurgical strategy
- Oncology
- Cancer research
- Human genomics
- Clinical research
- MinION
- Epigenetics
October 10 2021
Nanopore sequencing methods detect cell-free DNA associated with minimal residual disease and central nervous system infiltration in pediatric acute lymphoblastic leukemia
- Oncology
- DNA
- MinION
- Human genomics
- Clinical research
September 28 2021
High resolution copy number inference in cancer using short-molecule nanopore sequencing
- Oncology
- Human genomics
- Clinical research
- Cancer research
- DNA
- Structural variation
September 22 2021